https://www.healio.com/news/hematology-oncology/20230427/targeted-drug-demonstrates-safety-potential-to-stop-cancer-growth-in-early-trials
0
0
4/27/23 at 6:42am
Organization
Healio
Authors
A targeted cancer drug developed by researchers at Norwegian University of Science and Technology and spin-off company APIM Therapeutics has demonstrated positive findings in phase 1 trials, according to a paper published in Oncogene.“What we learned fr…
Create an account
or login to join the discussion